The primary conclusion derived from this study is that significant short- and long-term protection against hippocampal neuronal death is achieved by avoiding hyperoxic reperfusion following transient global cerebral ischemia. The results of this study expand upon those we previously reported using a clinically relevant model of canine cardiac arrest and resuscitation, demonstrating that normoxic resuscitation reduces early oxidative modifications to lipids and proteins, improves cerebral energy metabolism, and improves both short-term neuronal survival and neurologic outcome (Balan et al.,
2006; Liu et al.,
1998; Richards et al.,
2007; Vereczki et al.,
2006). Hyperoxic resuscitation significantly exacerbated hippocampal CA1 neuronal death at 24

h in the canine model, and at 7 and 30 days in the rat model (). Our cardiac arrest studies used exclusively females, whereas the rat global ischemia experiments used exclusively males, suggesting that the deleterious effects of hyperoxic resuscitation are not gender-specific. Hyperoxia also substantially worsened neurological outcome at 23

h in the canine model, but caused only subtle neurologic impairment at days 23–27 in the rat model, which was significantly different from shams, but not from normoxic-reperfused ischemic rats (). The differences in the degree to which ventilatory oxygen affects neurological outcome in the two models is most likely due to the differences in the extent of neuronal death throughout the brain in these two models, that both utilized 10

min of complete global cerebral ischemia. The canine cardiac arrest model is characterized by rapid and extensive neuronal death throughout all hippocampal subregions, several layers of the cortex, the Purkinje cell layer of the cerebellum, and in several additional locations (Rosenthal et al.,
2003; Williams et al.,
2006). In contrast, following 10

min of bilateral carotid occlusion plus bleeding hypotension in the rat, neuronal death is primarily limited to the CA1 subregion of the hippocampus and ventral regions of the thalamus, with relatively little neuropathology observed in other brain locations, including the cortex (Dietrich et al.,
1993).
The fact that only subtle alterations in learning and memory were detected in the hyperoxic reperfused rats, despite the robust loss of viable CA1 neurons in these animals, is not entirely unexpected and is consistent with a report by Olsen and associates (
1994), demonstrating similar correlation coefficients of <0.4 between surviving neurons and performance in the acquisition and probe tests. A longer duration of forebrain ischemia in the rat and more animals may be necessary to generate sufficient neurological impairment (which may include supporting brain regions), and power to detect significant differences in behavior between rats receiving hyperoxic and normoxic reperfusion. Regardless, preservation of neuronal cells is likely beneficial, and may be empirically revealed using a battery of tests designed to probe different demands placed on hippocampal function (Wishaw et al.,
1994).
Another important conclusion reached in this study is that cellular inflammatory reactions, represented by activation of both microglia and astrocytes, are robust and persistent throughout at least 30 days of reperfusion. Furthermore, these reactions are significantly reduced by normoxic compared to hyperoxic reperfusion, when measured at 7 but not 30 days following ischemia ( and ). While these cellular inflammatory responses are more commonly associated with focal cerebral ischemia (stroke), a comprehensive study by Sugawara and colleagues (
2002) demonstrated extensive microglial activation that started as early as 1 day after 10-min global cerebral ischemia and persisted for at least 56 days. Although not specifically quantified, these investigators also reported astrocyte activation at reperfusion periods of 28 and 56 days that was qualitatively similar to what we documented at 30 days reperfusion (). Both microglia and astrocytes perform critical neuroprotective functions (e.g., provision of neurotrophic factors); however, the results of several studies indicate that when these cells are highly activated, they can also contribute to neuronal injury and death through several mechanisms (e.g., production of reactive oxygen and nitrogen species) (Hailer,
2008). It is possible that the reduction in both microglial and astrocyte activation observed at 7 days post-ischemia with normoxic reperfusion contributes to improved long-term outcome; however, additional studies are necessary to support this hypothesis. Alternatively, the greater microglial and astrocyte activation observed at 7 days after hyperoxic reperfusion may simply be a consequence of greater ongoing cell death in this period.
In summary, while histological findings are supportive of the damaging effects of hyperoxic early reperfusion in this rat global cerebral ischemia model, the neurological findings fail to demonstrate a clear effect. Nevertheless, the results of these long-term outcome experiments with male rats, taken together with our previous results from short-term outcome studies with female dogs, call into question the appropriateness of indiscriminate clinical use of 100% ventilatory oxygen immediately after cardiac arrest. This concern was also expressed by the International Liaison Committee on Resuscitation, stating that “On the basis of preclinical evidence alone, unnecessary arterial hyperoxia should be avoided, especially during the initial post–cardiac arrest period” (Neumar et al.,
2008). Moreover, clinical studies indicate that normoxic resuscitation after neonatal asphyxiation improves outcome compared to that observed with hyperoxic resuscitation (Obladen,
2009; Rabi et al.,
2007). Additional clinical trials will be necessary to determine if the results we have obtained with both small and large animal models of global cerebral ischemia and reperfusion apply to resuscitation following cardiac arrest in humans.